*Disclaimer

GENETIC TECHNOLOGIES LIMITED (ASX: GTG)

🔗 📄 📈

GTG: Publication Validates geneType for Melanoma Risk Assessment

GENETIC TECHNOLOGIES LIMITED

2023-04-28 09:02:00

GTG: Publication Validates geneType Prostate Cancer Risk Test

GENETIC TECHNOLOGIES LIMITED

2023-04-19 09:22:00

GTG: GeneType MultiTest Panel Expanded Inclusion of New Diseases

GENETIC TECHNOLOGIES LIMITED

2023-03-27 09:52:00

GTG: Further Study Validates geneType Breast Cancer Risk Test

GENETIC TECHNOLOGIES LIMITED

2023-03-13 09:22:00

GTG: Receipt of R&D Tax Incentive Refund for geneType Multi Test

GENETIC TECHNOLOGIES LIMITED

2023-02-17 09:42:00

GTG: Publication Highlights geneType Outperforms Current Models

GENETIC TECHNOLOGIES LIMITED

2023-02-09 09:11:00

GTG: Supplementary Announcement - Comprehensive Risk Test

GENETIC TECHNOLOGIES LIMITED

2023-02-06 10:40:00

GTG: Genetic Technologies Announces US$5M Registered Direct Offer

GENETIC TECHNOLOGIES LIMITED

2023-02-06 09:43:00

GTG: World First Comprehensive Risk Test-Breast & Ovarian Cancer

GENETIC TECHNOLOGIES LIMITED

2023-02-03 09:43:00

GTG: GTG to form Strategic Alliance with global leader QIAGEN

GENETIC TECHNOLOGIES LIMITED

2023-02-01 09:56:00

GTG: Colorectal Cancer Model Presented at ASCOGI Cancer Symposium

GENETIC TECHNOLOGIES LIMITED

2023-01-24 14:35:00